Secukinumab versus adalimumab for treatment of active psoriatic arthritis (EXCEED): a double-blind, parallel-group, randomised, active-controlled, phase 3b trial

Authors: Iain B. McInnes, Frank Behrens, Philip J. Mease, Arthur Kavanaugh, Christopher T. Ritchlin, Peter Nash, Jordi Gratacós, Philippe Goupille, Т. В. Коротаева, Alice B. Gottlieb, Ruvie Martin, Kevin Ding, Pascale Pellet, Shephard Mpofu, Luminita Pricop - The Lancet 2020 cited by 282